证券代码：002215 证券简称：诺普信 深圳诺普信作物科学股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------------------|-------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | □ 特定对象调研 | □ 分析师会议 | | 投资者关系 | □ 媒体采访 | ☑ 业绩说明会 | | 活动类别 | □新闻发布会 | □路演活动 | | | □现场参观 | □其他 | | | | 中信证券、民生证券、天风证券、申万宏 ...

Investment Rating - The report maintains a "Buy" rating for the company [4]. Core Views - The company reported a year-on-year increase in revenue and net profit for the first three quarters of 2024, driven by the blueberry business, which saw a significant revenue increase of 248.41% [1]. - Despite a decline in revenue and net profit in Q3 2024 compared to the previous quarter, the overall performance for the first three quarters remains strong [1]. - The company is the largest pesticide formulation enterprise in China and is positioned for long-term growth with a focus on high-end planting [1]. Summary by Sections Financial Performance - For the first three quarters of 2024, the company achieved revenue of 3.894 billion yuan, a year-on-year increase of 27.30%, and a net profit of 488 million yuan, up 74.07% year-on-year [1]. - In Q3 2024, revenue was 494 million yuan, down 3.50% year-on-year and down 68.57% quarter-on-quarter; net profit was -65 million yuan, a slight decrease compared to the previous year [1]. - The gross profit margin for the first three quarters of 2024 was 34.03%, an increase of 4.39 percentage points year-on-year [1]. Business Segments - The blueberry business contributed significantly to revenue growth, with sales reaching 1.115 billion yuan, marking a 248.41% increase year-on-year [1]. - The number of controlling distributors decreased from 27 to 17, leading to a 23.14% decline in consolidated sales revenue from these distributors [1]. - The pesticide formulation business experienced a revenue decline of 3.97% due to falling sales prices [1]. Production and Capacity - As of the end of 2023, the company had pesticide production capacities of 26,000 tons for insecticides, 18,000 tons for fungicides, and 25,000 tons for herbicides [1]. - The company has received approval for multiple product registration certificates, expanding the range of products available for use [1]. Profit Forecast and Valuation - The report maintains profit forecasts for 2024-2026, expecting net profits of 619 million yuan, 770 million yuan, and 859 million yuan respectively [1]. - The company is positioned for long-term growth, with a focus on high-end agricultural practices [1].

Financial Performance - Revenue for Q3 2024 was CNY 494.32 million, a decrease of 3.50% compared to the same period last year[1] - Net profit attributable to shareholders was a loss of CNY 64.59 million, down 12.02% year-over-year[1] - Net profit excluding non-recurring items was a loss of CNY 94.52 million, a decrease of 37.33% compared to the previous year[1] - The net profit attributable to the parent company reached CNY 48,761.13 million, an increase of 74.07% compared to the previous year, primarily driven by increased sales in the blueberry business[6] - Net profit for Q3 2024 was ¥474,880,088.57, representing a 73.0% increase from ¥274,231,871.44 in Q3 2023[17] - The net profit attributable to the parent company for Q3 2024 is CNY 487,611,264.86, an increase from CNY 280,123,848.59 in Q3 2023, representing a growth of approximately 74.2%[18] - The total comprehensive income attributable to the parent company for Q3 2024 is CNY 486,647,046.88, compared to CNY 280,169,899.44 in Q3 2023, reflecting an increase of about 73.7%[18] Assets and Liabilities - Total assets increased to CNY 11.56 billion, reflecting a growth of 6.41% from the end of the previous year[2] - Total assets rose to ¥11,564,236,339.84, an increase of 6.4% compared to ¥10,867,931,839.75 in Q3 2023[14] - Total liabilities increased to ¥7,448,207,976.15, up 12.2% from ¥6,635,496,944.90 year-over-year[15] - Shareholder equity rose to CNY 3.86 billion, an increase of 3.03% year-over-year[2] - The company’s equity attributable to shareholders reached ¥3,863,973,009.30, up from ¥3,750,310,364.23 in the previous year[15] Cash Flow - Cash flow from operating activities for the year-to-date increased by 126.30% to CNY 107.69 million[1] - The net cash flow from operating activities for the first nine months of 2024 was CNY 10,769.14 million, a significant improvement of 126.30% from a net outflow of CNY 40,948.20 million in the same period last year[7] - Cash inflow from operating activities for Q3 2024 is CNY 3,459,787,583.54, compared to CNY 2,472,661,163.62 in Q3 2023, marking an increase of around 40%[19] - The net cash flow from operating activities for Q3 2024 is CNY 107,691,350.77, a significant recovery from a net outflow of CNY -409,482,009.64 in Q3 2023[19] - The net cash flow from investing activities improved by 41.43% to CNY -65,356.79 million, mainly due to the maturity of large deposits and structured deposits[7] - The net cash flow from investing activities for Q3 2024 is CNY -653,567,880.83, an improvement from CNY -1,115,930,923.27 in Q3 2023[20] - The net cash flow from financing activities decreased by 71.48% to CNY 40,508.59 million, primarily due to repayment of bank loans and increased purchases of minority shareholder equity[7] - The net cash flow from financing activities for Q3 2024 is CNY 405,085,907.70, down from CNY 1,420,515,442.50 in Q3 2023[20] Business Operations - The company reported a significant increase in blueberry business revenue, which grew by 248.41% year-over-year[5] - The company experienced a 49.47% increase in accounts receivable, attributed to uncollected payments from the peak season[5] - Sales expenses rose by 27.50% to CNY 35,470.22 million, mainly due to the expansion of the fresh blueberry business and increased advertising costs in the pesticide formulation business[6] - Management expenses surged by 63.98% to CNY 30,018.16 million, driven by the expansion of the blueberry business and increased employee compensation and benefits[6] - The company reported R&D expenses of ¥110,126,464.99, a 34.0% increase from ¥82,184,673.27 in Q3 2023[17] - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[16] Other Income and Expenses - The company recorded government subsidies of CNY 28.11 million during the reporting period[3] - Other income increased by 274.06% to CNY 4,427.61 million, primarily due to increased government subsidies[6] - The company reported a 93.36% increase in credit impairment losses, totaling CNY -7,131.51 million, due to an increase in receivables[6] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 32,423[8] - The basic earnings per share for Q3 2024 is CNY 0.4898, up from CNY 0.2867 in Q3 2023, indicating a growth of approximately 70.7%[19] Audit Status - The company has not undergone an audit for the Q3 2024 report[21]

深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2024-076 深圳诺普信作物科学股份有限公司 关于公司实际控制人部分股份质押的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性陈述或 重大遗漏。 深圳诺普信作物科学股份有限公司（以下简称"公司"）于近日收到实际控制人卢柏强 先生控制的公司深圳市诺普信投资控股有限公司（以下简称"诺普信控股"）的通知，获悉 诺普信控股将其持有的部分股份办理了股份质押，具体事项如下： | | 是否为第 | 质押 | 占其所 | 占公 | 是否为 | 是否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名 | 一大股东 | | | 司总 | | 为补 | 质押开 | 质押到期 | | 质押 | | 称 | 及一致行 | 股数 | 持股份 | 股本 | 限售股 | 充质 | 始日期 | 日 | 质权人 | 用途 | | | | （万股） | 比例 | | （注） | | | | | | | | 动人 ...

Financial Performance Forecast - The estimated net profit for the first three quarters of 2024 is expected to be between 448.19 million CNY and 504.22 million CNY, representing a year-on-year growth of 60% to 80% compared to 280.12 million CNY in the same period last year [2]. - The estimated net profit after deducting non-recurring gains and losses is expected to be between 398.08 million CNY and 454.10 million CNY, indicating a year-on-year growth of 51% to 73% compared to 262.45 million CNY last year [2]. - The estimated basic earnings per share for the first three quarters of 2024 is projected to be between 0.4504 CNY and 0.5067 CNY, compared to 0.2867 CNY in the same period last year [2]. Third Quarter Performance - For the third quarter of 2024, the estimated net loss attributable to shareholders is expected to be between 47.98 million CNY and 104 million CNY, compared to a loss of 57.66 million CNY in the same period last year [3]. - The estimated net loss after deducting non-recurring gains and losses for the third quarter is expected to be between 77.68 million CNY and 133.71 million CNY, compared to a loss of 68.82 million CNY last year [3]. - The basic earnings per share for the third quarter is projected to be a loss between 0.0569 CNY and 0.1132 CNY, compared to a loss of 0.0592 CNY in the same period last year [3]. Business Insights - The significant growth in revenue and profit is attributed to the blueberry business entering its second year of mass production [4]. - The third quarter is traditionally a low season for the company's pesticide formulation and fresh consumption businesses, leading to losses [4]. Investor Guidance - The performance forecast is based on preliminary calculations by the finance department and will be detailed in the Q3 2024 report [5]. - The company emphasizes the importance of timely information disclosure and advises investors to make cautious decisions and be aware of investment risks [5].

关于公司实际控制人及其一致行动人之间内部转让股份 的提示性公告 深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2024-074 深圳诺普信作物科学股份有限公司 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本计划概述 公司实际控制人卢柏强先生及其一致行动人控制的公司诺普信控股、西藏林 芝润宝盈信实业投资有限公司（现已更名为：云南润宝盈信农业有限公司，本文 简称"润宝盈信"）和卢翠冬女士合计持有公司股份353,913,939股，占公司总 股本的35.21%。 诺普信控股拟计划自公告披露之日起十五个交易日后三个月内以大宗交易 深圳诺普信作物科学股份有限公司公告 方式向实际控制人卢柏强先生转让公司股份不超过2,000万股(占公司总股本的 1.99%)。本计划的实施不会导致卢柏强先生及其一致行动人合计持股数量和持股 比例发生变化，也不会导致公司控股股东或实际控制人发生变化。 特别提示： 本次股份转让仅为公司实际控制人及其一致行动人之间通过大宗交易方式 进行的股份转让，不涉及向二级市场减持，不会导致公司实际控制人及其一致行 动人 ...

本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2024-073 深圳诺普信作物科学股份有限公司 关于会计师事务所名称变更的公告 深圳诺普信作物科学股份有限公司董事会 深圳诺普信作物科学股份有限公司于 2024 年 5 月 23 日召开 2023 年年度股 东大会，会议审议通过了《关于续聘公司审计机构的议案》，同意聘任深圳大华 国际会计师事务所（特殊普通合伙）（以下简称："深圳大华国际"）作为公司 2024 年度财务报告的审计机构。 近日，公司收到深圳大华国际来函告知，因业务发展需要，经主管部门批准， "深圳大华国际会计师事务所（特殊普通合伙）"名称已变更为"政旦志远（深 圳）会计师事务所（特殊普通合伙）"。除名称变更外，事务所各项执业资格、 服务团队、单位地址、联系电话等均无变化，原有的业务关系及已签定的合同继 续履行。更名后，原"深圳大华国际会计师事务所（特殊普通合伙）"的各项业 务、权利和义务由"政旦志远（深圳）会计师事务所（特殊普通合伙）"承继。 本次变更仅为名称变更，不 ...

深圳诺普信作物科学股份有限公司 关于公司董事、高级管理人员减持股份的预披露公告 深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2024-072 本公司及董事会全体成员保证公告内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 特别提示： 深圳诺普信作物科学股份有限公司（以下简称"公司"）副董事长王时豪先 生、副总经理谢文忠先生、李广泽先生计划自本公告之日起15个交易日后的三个 月内以集中竞价交易方式减持本公司股份,合计不超过757,400股（不超过公司股 份总数的0.08%）。 4、减持数量：合计不超过757,400股（不超过公司股份总数的0.08%），拟 减持数量不超过其所持公司股份总数的25%。 股东姓名 任职情况 持股数量 （股） 占公司总股 本比例（%） 拟减持数量 （股） 拟减持股份占公司 总股本比例（%） 王时豪 副董事长 1,008,412 0.10% 239,600 0.02% 谢文忠 副总经理 2,416,000 0.24% 256,000 0.03% 李广泽 副总经理 1,441,824 0.14% 261,800 0.03% 合计 4, ...

法律意见书 深圳市福田区深南大道6008号特区报业大厦42、41、31DE、2403、2405 电话(Tel):+86 755 83515666 传真(Fax):+86 755 83515333/83515090 网址(Website): www.grandall.com.cn 国浩律师（深圳）事务所 1．根据公司召开的第七届董事会第二次会议审议通过，公司决定召开2024 年第三次临时股东大会。 关于深圳诺普信作物科学股份有限公司 2024年第三次临时股东大会的法律意见书 GLG/SZ/A2008/FY/2024-938 致：深圳诺普信作物科学股份有限公司 国浩律师（深圳）事务所（以下称"本所"）接受深圳诺普信作物科学股份有 限公司（以下称"公司"）的委托，指派本所律师出席公司2024年第三次临时股东 大会（以下称"本次股东大会"），对本次股东大会的合法性进行见证。 本所律师根据《中华人民共和国公司法》（以下称"《公司法》"）、《上市 公司股东大会规则》（以下称"《股东大会规则》"）等法律、法规和规范性法律 文件以及《深圳诺普信作物科学股份有限公司章程》（以下称"《公司章程》"） 的规定，就公司本次股东大会的 ...

深圳诺普信作物科学股份有限公司公告 证券代码：002215 证券简称：诺普信 公告编号：2024-071 深圳诺普信作物科学股份有限公司 2024 年第三次临时股东大会决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、误导性 陈述或重大遗漏。 重要提示： 1、为维护中小投资者利益，提高中小投资者对公司股东大会决议的重大事项的参 与度，深圳诺普信作物科学股份有限公司（以下简称"公司"）本次临时股东大会审议 的议案对中小投资者单独计票。中小投资者是指除公司的董事、监事、高管和单独或合 计持有上市公司5%以上股份的股东以外的其他股东。 2、本次会议召开期间无增加、否决或变更提案的情况发生。 （3）召开方式：现场投票和网络投票相结合的方式 （4）召集人：本公司第七届董事会 （5）会议主持人：公司董事长卢柏强先生 深圳诺普信作物科学股份有限公司公告 一、会议召开和出席情况 1、会议召开情况 （1）现场召开时间：2024年9月13日下午14:30 网络投票时间为：2024年9月13日，其中，通过深圳证券交易所交易系统进行网络投 票的时间为2024年9月13日的交易时间，即上午9:15-9:25， ...